Business CBD Health & Medicine News

Companies Scramble for CBD Patents, Igniting Fear of Corporate Cannabis

Something of a corporate scramble is underway to secure patents for the various curative properties of CBD, and the associated products and procedures. Pharmaceutical firms anticipate a windfall, but some activists raise concerns about the creeping privatization of cannabinoids that should belong to the genetic and intellectual commons of the human race.

SHARE
RELATED POSTS
Los Angeles scraps marijuana tax ballot measure
Kush Bottles Launches New Division to Provide FDA-Compliant Packaging Solutions to the Pharmaceutical and Veterinary Industries
Want An SBA Loan? Think Again Marijuana Businesses

Leave Your Reply

*